Sign In
Get Clay Free →

Suggestions

    Paul Morrill

    CBO at bit bio

    Paul Morrill is an experienced executive and entrepreneur in the biotechnology industry who currently serves as the Chief Business Officer (CBO) at bit bio. Here are some key details about Paul Morrill:

    Background and Education

    • Holds a Bachelor's degree in Biochemistry from the University of California, Davis
    • Earned a PhD in Biophysics and Biotechnology from the University of Cambridge

    Professional Experience

    • Chief Business Officer (CBO) at bit bio, a cell coding company focused on producing human cells for research, drug discovery, and cell therapy1
    • Co-founder and former Commercial Founder and President of Products at Horizon Discovery Group2
    • Founder of CellRx Limited, a growth factors company serving the biopharmaceutical, stem cell and research sectors2
    • Has over 30 years of experience in the biotech and pharmaceutical industries3

    Expertise and Contributions

    • Known for his entrepreneurial skills and successful ventures in biotechnology
    • Strengths include business development, innovation, revenue generation, and organizational leadership
    • Joined bit bio to help achieve the company's goal of developing a scalable technology platform capable of producing consistent batches of every human cell type12

    Paul Morrill's extensive experience and strategic insights have significantly contributed to the growth and success of various companies in the biotechnology sector, particularly in his current role at bit bio.4

    Highlights

    Oct 29 · bit.bio
    Start-up Bit Bio expands leadership team
    Start-up Bit Bio expands leadership team
    Oct 14 · bit.bio
    Introducing Bit Bio — coding cells, the building blocks of life.

    Related Questions

    What are Paul Morrill's key achievements at bit bio?
    How did Paul Morrill's previous roles prepare him for his position at bit bio?
    What is the significance of Paul Morrill's educational background in his career?
    How does bit bio's technology differ from traditional stem cell approaches?
    What are the main challenges bit bio is addressing in the biotechnology industry?
    Paul Morrill
    Paul Morrill, photo 1
    Paul Morrill, photo 2
    Get intro to Paul
    Add to my network

    Location

    Greater Cambridge Area